Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Neoplasms of the CNS

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    March 2010
  1. ARUGA J , Nozaki Y, Hatayama M, Odaka YS, et al
    Expression of ZIC family genes in meningiomas and other brain tumors.
    BMC Cancer. 2010;10:79.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  2. YAN DF , Yan SX, Yang JS, Wang YX, et al
    Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature.
    BMC Cancer. 2010;10:49.
    PubMed     Text format     Related articles    Abstract available


  3. MORANDI L , Franceschi E, De Biase D, Marucci G, et al
    Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.
    BMC Cancer. 2010;10:48.
    PubMed     Text format     Related articles    Abstract available


  4. REITHMEIER T , Graf E, Piroth T, Trippel M, et al
    BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors.
    BMC Cancer. 2010;10:30.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  5. REN Y , Zhou X, Mei M, Yuan XB, et al
    MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
    BMC Cancer. 2010;10:27.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  6. WANG J , Miletic H, Sakariassen PO, Huszthy PC, et al
    A reproducible brain tumour model established from human glioblastoma biopsies.
    BMC Cancer. 2009;9:465.
    PubMed     Text format     Related articles    Abstract available


  7. SCHRADER J , Deuster O, Rinn B, Schulz M, et al
    Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.
    BMC Cancer. 2009;9:464.
    PubMed     Text format     Related articles    Abstract available


  8. PARK CK , Lee SH, Han JH, Kim CY, et al
    Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
    BMC Cancer. 2009;9:450.
    PubMed     Text format     Related articles    Abstract available


  9. MOSER JJ , Fritzler MJ, Rattner JB
    Primary ciliogenesis defects are associated with human astrocytoma/ glioblastoma cells.
    BMC Cancer. 2009;9:448.
    PubMed     Text format     Related articles    Abstract available


  10. GOETZE S , Feldhaus V, Traska T, Wolter M, et al
    ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
    BMC Cancer. 2009;9:447.
    PubMed     Text format     Related articles    Abstract available


  11. VERHOEFF JJ , van Tellingen O, Claes A, Stalpers LJ, et al
    Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.
    BMC Cancer. 2009;9:444.
    PubMed     Text format     Related articles    Abstract available


  12. JANTARATNOTAI N , Choi HB, McLarnon JG
    ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.
    BMC Cancer. 2009;9:442.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  13. CARSON-WALTER EB , Winans BN, Whiteman MC, Liu Y, et al
    Characterization of TEM1/endosialin in human and murine brain tumors.
    BMC Cancer. 2009;9:417.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  14. ROBE PA , Martin DH, Nguyen-Khac MT, Artesi M, et al
    Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults.
    BMC Cancer. 2009;9:372.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  15. BEIER CP , Schmid C, Gorlia T, Kleinletzenberger C, et al
    RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study.
    BMC Cancer. 2009;9:308.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  16. MERTSCH S , Schurgers LJ, Weber K, Paulus W, et al
    Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.
    BMC Cancer. 2009;9:302.
    PubMed     Text format     Related articles    Abstract available


  17. TEN HAAF A , Bektas N, von Serenyi S, Losen I, et al
    Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.
    BMC Cancer. 2009;9:298.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  18. BOUMENDJEL A , McLeer Florin A, Champelovier P, Allegro D, et al
    A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.
    BMC Cancer. 2009;9:242.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  19. LI J , Qin Z, Liang Z
    The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells.
    BMC Cancer. 2009;9:215.
    PubMed     Text format     Related articles    Abstract available


  20. STAFLIN K , Zuchner T, Honeth G, Darabi A, et al
    Identification of proteins involved in neural progenitor cell targeting of gliomas.
    BMC Cancer. 2009;9:206.
    PubMed     Text format     Related articles    Abstract available


  21. VALENSIN S , Ghiron C, Lamanna C, Kremer A, et al
    KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?
    BMC Cancer. 2009;9:196.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  22. ARRIETA O , Saavedra-Perez D, Kuri R, Aviles-Salas A, et al
    Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis.
    BMC Cancer. 2009;9:119.
    PubMed     Text format     Related articles    Abstract available


  23. NIEDER C , Marienhagen K, Astner ST, Molls M, et al
    Prognostic scores in brain metastases from breast cancer.
    BMC Cancer. 2009;9:105.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  24. FABI A , Metro G, Russillo M, Vidiri A, et al
    Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.
    BMC Cancer. 2009;9:101.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  25. BOULAY JL , Stiefel U, Taylor E, Dolder B, et al
    Loss of heterozygosity of TRIM3 in malignant gliomas.
    BMC Cancer. 2009;9:71.
    PubMed     Text format     Related articles    Abstract available


  26. RIESKE P , Golanska E, Zakrzewska M, Piaskowski S, et al
    Arrested neural and advanced mesenchymal differentiation of glioblastoma cells- comparative study with neural progenitors.
    BMC Cancer. 2009;9:54.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  27. KIM JY , Kim YJ, Lee S, Park JH, et al
    The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells.
    BMC Cancer. 2009;9:27.
    PubMed     Text format     Related articles    Abstract available


  28. VON BUEREN AO , Shalaby T, Oehler-Janne C, Arnold L, et al
    RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.
    BMC Cancer. 2009;9:10.
    PubMed     Text format     Related articles    Abstract available


  29. CHOSDOL K , Misra A, Puri S, Srivastava T, et al
    Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors.
    BMC Cancer. 2009;9:5.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  30. MONTGOMERY JP , Patterson PH
    Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
    BMC Cancer. 2008;8:354.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  31. HUANG Q , Zhang QB, Dong J, Wu YY, et al
    Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    BMC Cancer. 2008;8:304.
    PubMed     Text format     Related articles    Abstract available


  32. MACHADO CM , Ikemori RY, Zorzeto TQ, Nogueira AC, et al
    Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro.
    BMC Cancer. 2008;8:291.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  33. SANCHEZ-DIAZ PC , Burton TL, Burns SC, Hung JY, et al
    Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
    BMC Cancer. 2008;8:280.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  34. LUCIO-ETEROVIC AK , Cortez MA, Valera ET, Motta FJ, et al
    Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas.
    BMC Cancer. 2008;8:243.
    PubMed     Text format     Related articles    Abstract available


  35. HALDORSEN IS , Krakenes J, Goplen AK, Dunlop O, et al
    AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.
    BMC Cancer. 2008;8:225.
    PubMed     Text format     Related articles    Abstract available


    March 2008
  36. WANG LF , Fokas E, Juricko J, You A, et al
    Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    BMC Cancer. 2008;8:79.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


    February 2008
  37. LIN TH , Kuo HC, Chou FP, Lu FJ, et al
    Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
    BMC Cancer. 2008;8:58.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


    January 2008
  38. HUA C , Qiang H, Jun D, De-Zhong Z, et al
    Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.
    BMC Cancer. 2008;8:29.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  39. VON HOFF K , Kieffer V, Habrand JL, Kalifa C, et al
    Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications.
    BMC Cancer. 2008;8:15.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  40. NOMIYA T , Nemoto K, Kumabe T, Takai Y, et al
    Prospective single-arm study of 72 Gy hyperfractionated radiation therapy and combination chemotherapy for anaplastic astrocytomas.
    BMC Cancer. 2008;8:11.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


    October 2007
  41. HILDEBRANDT B , Muller C, Pezzutto A, Daniel PT, et al
    Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study.
    BMC Cancer. 2007;7:185.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


    January 2007
  42. ASSIMAKOPOULOU M , Kondyli M, Gatzounis G, Maraziotis T, et al
    Neurotrophin receptors expression and JNK pathway activation in human astrocytomas.
    BMC Cancer. 2007;7:202.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


  43. MISRA A , Chattopadhyay P, Chosdol K, Sarkar C, et al
    Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis.
    BMC Cancer. 2007;7:190.
    PubMed     Text format     Related articles    Abstract available   Free Full Text


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: